Keywords:
Abdominal Viscera, Gastrointestinal tract, Pancreas, MR, Cholangiography, Contrast agent-intravenous, Cysts, Inflammation, Retrospective, Observational, Performed at one institution
Authors:
C. Gullì1, A. Marrazzo1, G. Restaino2, M. Missere3, E. Cucci2, G. Sallustio3; 1Roma/IT, 2CAMPOBASSO/IT, 3Campobasso (CB)/IT
DOI:
10.26044/ecr2020/C-13446
Methods and materials
We have enrolled 252 asymptomatic patients with an abnormal increase of serum pancreatic enzymes (mean age: 51 ± 14 y/o; M:F = 133:119). All of them underwent s-MRCP at our Institution from February 2007 to November 2018.
We excluded patients with pancreatic symptoms, previous GI surgery or ERCP and other conditions that could cause hyperenzymemia (macroamylasemia, coeliac disease, renal impairment, chronic viral hepatitis, salivary hyperamylasaemia).
All the examinations have performed with a 1.5 T scanner and an 8-channel phased-array surface coil according to the same image protocol.
The MR examination required 6 hours of prior fasting, in order to minimize intestinal peristalsis.
Just before getting on the MRI table, administration of negative oral contrast agent (180 ml of pineapple juice with 1 ml of Gd-DOTA) helped to avoid obscuration of the pancreatic ducts by the high signal intensity in the overlying stomach and duodenum. The examination was performed with the patient in the supine position.